Valproic acid could help in the fight against COVID-19: A case–control study

O. Moreno-Pérez,E. Merino, J. Manuel Ramos, J. Carlos Rodríguez,C. Diaz, P. Mas,S. Reus,R. Sánchez-Martínez,V. Boix,P. Chico-Sánchez, J. Sánchez-Payá,J. Portilla

Neurologia (Barcelona, Spain)(2022)

引用 2|浏览13
暂无评分
摘要
Patients with VPA within the therapeutic range had a reduction of SARS-Cov-2 infection incidence greater than 75%. There is a downward trend in the risk of COVID-19 admission by SARS-CoV-2 in patients on VPA therapy. These findings warrant further investigation.
更多
查看译文
关键词
Valproic acid,COVID-19,Incidence,Hospital admission,Spain
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要